Amanta Healthcare Limited

Amanta Healthcare Limited specializes in ophthalmic products, primarily manufacturing lubricating eye drops. These include hypromellose-based formulations like AaproMel and Optavid, as well as variants containing carmellose sodium (e.g., eyeon DUE-Carmellose) and hyaluronic acid (e.g., HYALU TEARS Eye Drop). The company also produces topical lubricants such as Aqualube and single-use eye drops like ARTI-TEARS. Additionally, they supply compression therapy devices—such as Clinipod, Actipod, and Easypod—for managing venous leg ulcers.

Amanta Healthcare Limited is headquartered in India. The company’s global focus ensures its products are designed to meet international healthcare needs while maintaining affordability and quality.

Amanta Healthcare Limited’s devices are registered in the eudamed database, which is the official EU portal for medical device information. This registry is used for transparency and compliance tracking within the European Union.

All of Amanta Healthcare Limited’s devices fall under EU Class IIa classification. This classification is assigned based on risk assessment criteria, where Class IIa devices pose a moderate risk and require compliance with specific EU Medical Device Regulations (MDR) or In Vitro Diagnostic Regulation (IVDR) requirements, including clinical evaluations and conformity assessments.